Promising malaria vaccine candidates enter key trial in african children
NCT ID NCT07183371
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 28 times
Summary
This study tests two experimental malaria vaccines in 360 children aged 5 to 36 months living in Burkina Faso, where malaria is common. The vaccines aim to prevent the disease by training the immune system to fight the malaria parasite. Researchers will monitor safety and check how many children get malaria over 6 months after vaccination.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA,FALCIPARUM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institut de Recherche en Sciences de la Sante - Clinical Research Unit of Nanoro (IRSS-URCN)
Nanoro, Burkina Faso
Conditions
Explore the condition pages connected to this study.